Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer
This randomized controlled Phase III trial was designed to evaluate the effect of vitamin D supplementation (VD) on chemotherapy side effects following adjuvant chemotherapy in breast cancer
• Age between 18 and 80 years, with an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.
• Primary diagnosis of breast cancer confirmed by preoperative pathological examination.
• Serum 25(OH)D levels less than 20 ng/ml (50 nmol/L).
• Patients who have not previously received chemotherapy and who plan to undergo at least 4 cycles of
• Patients with adjuvant chemotherapy or combined targeted therapy.
• Life expectancy of at least 6 months.
• No other uncontrolled benign diseases at the time of recruitment.
• All patients must have complete clinical medical records.
• Willingness to voluntarily sign an informed consent form.